Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Chen

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Infection Control and Hospital Epidemiology|September 23, 2025
Associations between routine oral care and in-hospital mobility with non-ventilator hospital-acquired pneumoniaSheryl A Kluberg, Tom Chen, Rui Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin hSheo B Singh, Weiguo Liu, Xiaohua Li, et al.
Vaccine|October 22, 2008
A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malariaElissa Malkin, Jinhong Hu, Zhen Li, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Infection Control and Hospital Epidemiology|September 23, 2025
Associations between routine oral care and in-hospital mobility with non-ventilator hospital-acquired pneumoniaSheryl A Kluberg, Tom Chen, Rui Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin hSheo B Singh, Weiguo Liu, Xiaohua Li, et al.
Vaccine|October 22, 2008
A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malariaElissa Malkin, Jinhong Hu, Zhen Li, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
Pageof 7